Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 998 | 1020 | 1033 | 1087 | 1037 | 967 |
| Fund Return | -0.23% | 2.01% | 3.29% | 2.81% | 0.73% | -0.33% |
| Place in category | 3202 | 1057 | 2196 | - | - | - |
| % in Category | 98 | 34 | 71 | - | - | - |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| APO Forte INKA | 453.7M | 7.58 | 10.99 | 4.63 | ||
| APO Mezzo INKA | 339.82M | 0.71 | 6.04 | 2.31 | ||
| HSBC Trinkaus AlphaScreen | 161.57M | 3.04 | 11.43 | 4.96 | ||
| HSBC Trinkaus Strategie Dynamik | 113.94M | 1.73 | 10.77 | 6.02 | ||
| HSBC Strategie Balanced | 52.62M | 1.33 | 7.30 | 3.56 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| PrivatFonds: Kontrolliert pro | 2.85B | 4.17 | 11.62 | 5.33 | ||
| BBBank Kontinuitat Union | 1.51B | 1.56 | 11.72 | 4.64 | ||
| Substanz Fonds | 1.44B | 1.13 | 7.31 | 5.59 | ||
| UniStrategie:Ausgewogen | 1.15B | 1.39 | 7.99 | 4.47 | ||
| Allianz Strategiefonds Balance IT2 | 1.13B | 1.10 | 10.87 | 5.95 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Lithuania (Republic Of) | XS1619567677 | 3.08 | - | - | |
| Btp-1nv29 5,25% | IT0001278511 | 2.87 | 109.11 | -0.46% | |
| British Columbia (Province Of) | - | 2.73 | - | - | |
| Italy .25 15-Mar-2028 | IT0005433690 | 2.49 | 95.840 | -0.22% | |
| Novartis | CH0012005267 | 2.45 | 124.80 | -2.26% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Buy | Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review